ArticleCancer medicine2024

Efficacy and side effects of anti-CD19 CAR T-cell therapy in patients with relapsed/refractory gastrointestinal lymphoma.

Yi Li Jiang et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.